12-8602830-T-TC
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_020661.4(AICDA):c.*1453_*1454insG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0128 in 119,618 control chromosomes in the GnomAD database, including 18 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.013 ( 18 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
AICDA
NM_020661.4 3_prime_UTR
NM_020661.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.39
Genes affected
AICDA (HGNC:13203): (activation induced cytidine deaminase) This gene encodes a RNA-editing deaminase that is a member of the cytidine deaminase family. AICDA is specifically expressed and active in germinal center-like B cells. In the germinal center, AICDA is involved in somatic hypermutation, gene conversion, and class-switch recombination of immunoglobulin genes. An epigenetic role in neoplastic transformation and lymphoma progression has been experimentally ascribed to AICDA using mouse models. Defects in this gene are the cause of autosomal recessive hyper-IgM immunodeficiency syndrome type 2 (HIGM2). [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0615 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AICDA | NM_020661.4 | c.*1453_*1454insG | 3_prime_UTR_variant | 5/5 | ENST00000229335.11 | NP_065712.1 | ||
AICDA | NM_001330343.2 | c.*1453_*1454insG | 3_prime_UTR_variant | 5/5 | NP_001317272.1 | |||
AICDA | NM_001410970.1 | c.*1496_*1497insG | 3_prime_UTR_variant | 4/4 | NP_001397899.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AICDA | ENST00000229335.11 | c.*1453_*1454insG | 3_prime_UTR_variant | 5/5 | 1 | NM_020661.4 | ENSP00000229335 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1537AN: 119632Hom.: 18 Cov.: 31
GnomAD3 genomes
AF:
AC:
1537
AN:
119632
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 134Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 98
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
134
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
98
Gnomad4 AFR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0128 AC: 1537AN: 119618Hom.: 18 Cov.: 31 AF XY: 0.0127 AC XY: 739AN XY: 58298
GnomAD4 genome
AF:
AC:
1537
AN:
119618
Hom.:
Cov.:
31
AF XY:
AC XY:
739
AN XY:
58298
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hyperimmunoglobulin M syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at